Ameriprise Financial (AMP)
NYSEFinancialsAsset ManagementSnapshot 2026-07-08
$490.30-3.45%
Close 2026-07-08 · 1-day change
Reading AMP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AMP free→NYSEFinancialsAsset ManagementSnapshot 2026-07-08
Reading AMP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track AMP free→QuarterlyIQ Insights · AMP
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $490.30. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $508 AMP trades at 12× p/e, below its 19× p/e peer median, but our blended $421 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $452–$560. Note: our $421 fair value sits below the entire analyst range ($452–$560). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Not investment advice.
$452.00 – $560.00 (median $471.00) · 5 analysts · as of 2026-05-04
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $471.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $60.94 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $91.59 | — | — | Hist. CAGR | high |
| graham number | 12M | $246.46 | — | — | TTM | high |
| Peer P/B | 12M | $112.18 | 1.7 | 65.74 | TTM | high |
| Peer P/FCF | 12M | $208.26 | 13.7 | 15.21 | TTM | high |
| Peer P/E | 12M | $748.97 | 18.2 | 41.07 | TTM | high |
| Peer P/S | 12M | $608.83 | 3.0 | 204.40 | TTM | high |
| PEG | 12M | $539.83 | 13.1 | 41.07 | TTM | high |
| residual income | 12M | $195.90 | — | — | TTM | high |
| Own P/E history | 12M | $489.16 | 11.9 | 41.07 | TTM | high |
| triangulated | 12M | $750.77 | 18.2 | 41.17 | Triangulated | high |
| Peer P/B | 3Y | $168.16 | 1.7 | 98.54 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $61.39 | 13.7 | 4.48 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $931.66 | 18.2 | 51.09 | Analyst | medium |
| Peer P/S | 3Y | $681.34 | 3.0 | 228.75 | Analyst | medium |
| PEG | 3Y | $671.51 | 13.1 | 51.09 | Analyst | medium |
| Own P/E history | 3Y | $608.47 | 11.9 | 51.09 | Analyst | medium |
| Peer P/B | 5Y | $220.25 | 1.7 | 129.07 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $1002.63 | 18.2 | 54.98 | Analyst | high |
| Peer P/S | 5Y | $733.24 | 3.0 | 246.17 | Analyst | high |
| PEG | 5Y | $722.66 | 13.1 | 54.98 | Analyst | high |
| Own P/E history | 5Y | $654.82 | 11.9 | 54.98 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.